Статья

MARKETING ANALYSIS OF DRUGS USED FOR VIRAL HEPATITIS IN THE REPUBLIC OF UZBEKISTAN

Gulchexra MamatisakovaAziza TuxtayevaRano AlievaCandidate of Pharmaceutical Sciences, Dotcent, Tashkent Pharmaceutical Institute, Uzbekistan, Tashkent

Universum Medicine & pharmacologyjournal2021en

ABI

Аннотация

An marketing analysis of hepatoprotectors of the Republic of Uzbekistan was carried out according to the State registers of medicines and medical devices No. 22 for 2018; No.23 for 2019; No24 for 2020 according to research. Medicines for the treatment of viral hepatitis. 2018-2019 of the total number of 28.7% is accounted for by domestic producers. The number of drugs for the treatment of viral hepatitis of domestic pharmaceutical manufacturers 2018-2020 increased from 30 to 31 positions.

Темы

Education, Innovation and Language Studies Economic and Industrial Development Economic, Social, and Public Health Issues in Russia and Globally

Идентификаторы

DOI: 10.32743/unimed.2021.78.6.11900

Цитирования и источники

Цитирований: 0Использованных источников: 0

Показатели — AkademScholar · Скоро